CoChat

Evaluation of neuroprotective effect of glucagon‐like peptide 1 analogs using neuroimaging

Femminella, Grazia D., Edison, Paul · 2014 · Alzheimer's & Dementia
Cited by 41

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

There is increasing evidence to suggest that glucagon‐like peptide 1 (GLP1) analogs are neuroprotective in animal models. In transgenic mice, both insulin and GLP1 analogs reduced inflammation, increased stem cell proliferation, reduced apoptosis, and increased dendritic growth. Furthermore, insulin desensitization was also observed in these animals, and reduced glucose uptake in the brain, as shown on FDG‐PET imaging. In this review we discussed the role of PET and MRI in evaluating the effect of GLP1 analogs in disease progression in both Alzheimer's and Parkinson's disease. We have also discussed the potential novel PET markers that will allow us to understand the mechanism by which GLP1 exerts its effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2013.12.012

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 41

Metadata

Authors
Femminella, G. D., & Edison, P.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2014-02
Volume
10
Issue
1S
Pages
S55-61
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2041896116
Cited by
41
References
20
FWCI
3.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of neuroprotective effect of glucagon‐like peptide 1 analogs using neuroimaging. https://app.cochat.ai/papers/10.1016/j.jalz.2013.12.012
The paper
Femminella, G. D., & Edison, P. (2014). Evaluation of neuroprotective effect of glucagon‐like peptide 1 analogs using neuroimaging. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2013.12.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.